nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—ACHE—Irinotecan—lung cancer	0.294	0.478	CbGbCtD
Ephedrine—BCHE—Irinotecan—lung cancer	0.177	0.288	CbGbCtD
Ephedrine—BCHE—Cisplatin—lung cancer	0.144	0.235	CbGbCtD
Ephedrine—BCHE—diaphragm—lung cancer	0.00645	0.455	CbGeAlD
Ephedrine—Pseudoephedrine—IL2—lung cancer	0.00261	0.39	CrCbGaD
Ephedrine—Bradycardia—Irinotecan—lung cancer	0.000935	0.00405	CcSEcCtD
Ephedrine—Selegiline—CYP2A6—lung cancer	0.000934	0.139	CrCbGaD
Ephedrine—Delirium—Doxorubicin—lung cancer	0.000918	0.00397	CcSEcCtD
Ephedrine—Nausea—Pemetrexed—lung cancer	0.000916	0.00396	CcSEcCtD
Ephedrine—Nausea—Gefitinib—lung cancer	0.00091	0.00393	CcSEcCtD
Ephedrine—Anorexia—Vinblastine—lung cancer	0.000908	0.00393	CcSEcCtD
Ephedrine—Asthenia—Teniposide—lung cancer	0.000896	0.00387	CcSEcCtD
Ephedrine—Hyperhidrosis—Topotecan—lung cancer	0.000895	0.00387	CcSEcCtD
Ephedrine—SLC6A2—respiratory system—lung cancer	0.000891	0.0629	CbGeAlD
Ephedrine—Anorexia—Topotecan—lung cancer	0.000882	0.00381	CcSEcCtD
Ephedrine—Dysuria—Paclitaxel—lung cancer	0.000876	0.00379	CcSEcCtD
Ephedrine—Anorexia—Erlotinib—lung cancer	0.000873	0.00377	CcSEcCtD
Ephedrine—Vertigo—Vinorelbine—lung cancer	0.000871	0.00377	CcSEcCtD
Ephedrine—Palpitations—Vinorelbine—lung cancer	0.000857	0.00371	CcSEcCtD
Ephedrine—Bradycardia—Cisplatin—lung cancer	0.000849	0.00367	CcSEcCtD
Ephedrine—Hypertension—Vinorelbine—lung cancer	0.000837	0.00362	CcSEcCtD
Ephedrine—Insomnia—Erlotinib—lung cancer	0.000828	0.00358	CcSEcCtD
Ephedrine—Decreased appetite—Vinblastine—lung cancer	0.000828	0.00358	CcSEcCtD
Ephedrine—Chest pain—Vinorelbine—lung cancer	0.000826	0.00357	CcSEcCtD
Ephedrine—Dyspnoea—Topotecan—lung cancer	0.000825	0.00357	CcSEcCtD
Ephedrine—Arrhythmia—Irinotecan—lung cancer	0.000821	0.00355	CcSEcCtD
Ephedrine—Dyspnoea—Erlotinib—lung cancer	0.000816	0.00353	CcSEcCtD
Ephedrine—Pain—Vinblastine—lung cancer	0.000815	0.00352	CcSEcCtD
Ephedrine—Dyspepsia—Topotecan—lung cancer	0.000815	0.00352	CcSEcCtD
Ephedrine—Dyspepsia—Erlotinib—lung cancer	0.000806	0.00348	CcSEcCtD
Ephedrine—Decreased appetite—Topotecan—lung cancer	0.000804	0.00348	CcSEcCtD
Ephedrine—Arrhythmia—Gemcitabine—lung cancer	0.0008	0.00346	CcSEcCtD
Ephedrine—Decreased appetite—Erlotinib—lung cancer	0.000796	0.00344	CcSEcCtD
Ephedrine—Vomiting—Teniposide—lung cancer	0.000794	0.00343	CcSEcCtD
Ephedrine—Pain—Topotecan—lung cancer	0.000791	0.00342	CcSEcCtD
Ephedrine—Rash—Teniposide—lung cancer	0.000787	0.0034	CcSEcCtD
Ephedrine—Dermatitis—Teniposide—lung cancer	0.000786	0.0034	CcSEcCtD
Ephedrine—Feeling abnormal—Vinblastine—lung cancer	0.000785	0.00339	CcSEcCtD
Ephedrine—Pain—Erlotinib—lung cancer	0.000783	0.00339	CcSEcCtD
Ephedrine—Headache—Teniposide—lung cancer	0.000782	0.00338	CcSEcCtD
Ephedrine—Amphetamine—CYP2A6—lung cancer	0.000776	0.116	CrCbGaD
Ephedrine—SLC18A2—lung—lung cancer	0.000776	0.0547	CbGeAlD
Ephedrine—Angina pectoris—Docetaxel—lung cancer	0.000773	0.00334	CcSEcCtD
Ephedrine—Tachycardia—Vinorelbine—lung cancer	0.000773	0.00334	CcSEcCtD
Ephedrine—Muscle spasms—Irinotecan—lung cancer	0.000769	0.00333	CcSEcCtD
Ephedrine—Bradycardia—Paclitaxel—lung cancer	0.000763	0.0033	CcSEcCtD
Ephedrine—Feeling abnormal—Topotecan—lung cancer	0.000763	0.0033	CcSEcCtD
Ephedrine—Anorexia—Vinorelbine—lung cancer	0.000755	0.00326	CcSEcCtD
Ephedrine—Arrhythmia—Cisplatin—lung cancer	0.000745	0.00322	CcSEcCtD
Ephedrine—Nausea—Teniposide—lung cancer	0.000742	0.00321	CcSEcCtD
Ephedrine—BCHE—respiratory system—lung cancer	0.000737	0.052	CbGeAlD
Ephedrine—Body temperature increased—Topotecan—lung cancer	0.000732	0.00316	CcSEcCtD
Ephedrine—Body temperature increased—Erlotinib—lung cancer	0.000724	0.00313	CcSEcCtD
Ephedrine—Vertigo—Irinotecan—lung cancer	0.000719	0.00311	CcSEcCtD
Ephedrine—Dyspnoea—Vinorelbine—lung cancer	0.000706	0.00305	CcSEcCtD
Ephedrine—Muscle spasms—Cisplatin—lung cancer	0.000698	0.00302	CcSEcCtD
Ephedrine—ADRA1A—epithelium—lung cancer	0.000692	0.0489	CbGeAlD
Ephedrine—Benzyl alcohol—CYP2E1—lung cancer	0.000691	0.103	CrCbGaD
Ephedrine—Hypertension—Irinotecan—lung cancer	0.000691	0.00299	CcSEcCtD
Ephedrine—Decreased appetite—Vinorelbine—lung cancer	0.000688	0.00298	CcSEcCtD
Ephedrine—Asthenia—Vinblastine—lung cancer	0.000683	0.00296	CcSEcCtD
Ephedrine—Benzyl alcohol—CYP1A1—lung cancer	0.000682	0.102	CrCbGaD
Ephedrine—Tremor—Cisplatin—lung cancer	0.00068	0.00294	CcSEcCtD
Ephedrine—Pain—Vinorelbine—lung cancer	0.000677	0.00293	CcSEcCtD
Ephedrine—Hypertension—Gemcitabine—lung cancer	0.000673	0.00291	CcSEcCtD
Ephedrine—Arrhythmia—Paclitaxel—lung cancer	0.000669	0.0029	CcSEcCtD
Ephedrine—Asthenia—Topotecan—lung cancer	0.000664	0.00287	CcSEcCtD
Ephedrine—Chest pain—Gemcitabine—lung cancer	0.000663	0.00287	CcSEcCtD
Ephedrine—Selegiline—CYP2E1—lung cancer	0.000663	0.0989	CrCbGaD
Ephedrine—Confusional state—Irinotecan—lung cancer	0.000658	0.00285	CcSEcCtD
Ephedrine—Asthenia—Erlotinib—lung cancer	0.000657	0.00284	CcSEcCtD
Ephedrine—Feeling abnormal—Vinorelbine—lung cancer	0.000652	0.00282	CcSEcCtD
Ephedrine—Tension—Paclitaxel—lung cancer	0.00064	0.00277	CcSEcCtD
Ephedrine—Muscle spasms—Etoposide—lung cancer	0.00064	0.00277	CcSEcCtD
Ephedrine—Nervousness—Paclitaxel—lung cancer	0.000634	0.00274	CcSEcCtD
Ephedrine—Irritability—Methotrexate—lung cancer	0.000632	0.00273	CcSEcCtD
Ephedrine—Hyperhidrosis—Irinotecan—lung cancer	0.000631	0.00273	CcSEcCtD
Ephedrine—Dizziness—Vinblastine—lung cancer	0.00063	0.00272	CcSEcCtD
Ephedrine—Muscle spasms—Paclitaxel—lung cancer	0.000627	0.00271	CcSEcCtD
Ephedrine—Body temperature increased—Vinorelbine—lung cancer	0.000626	0.00271	CcSEcCtD
Ephedrine—Anorexia—Irinotecan—lung cancer	0.000622	0.00269	CcSEcCtD
Ephedrine—Anxiety—Cisplatin—lung cancer	0.000616	0.00266	CcSEcCtD
Ephedrine—Hyperhidrosis—Gemcitabine—lung cancer	0.000615	0.00266	CcSEcCtD
Ephedrine—Dizziness—Topotecan—lung cancer	0.000612	0.00265	CcSEcCtD
Ephedrine—Tremor—Paclitaxel—lung cancer	0.000611	0.00264	CcSEcCtD
Ephedrine—BCHE—bronchus—lung cancer	0.000606	0.0428	CbGeAlD
Ephedrine—Anorexia—Gemcitabine—lung cancer	0.000606	0.00262	CcSEcCtD
Ephedrine—Vomiting—Vinblastine—lung cancer	0.000606	0.00262	CcSEcCtD
Ephedrine—Dizziness—Erlotinib—lung cancer	0.000605	0.00262	CcSEcCtD
Ephedrine—Agitation—Paclitaxel—lung cancer	0.0006	0.00259	CcSEcCtD
Ephedrine—Vertigo—Etoposide—lung cancer	0.000598	0.00259	CcSEcCtD
Ephedrine—Headache—Vinblastine—lung cancer	0.000597	0.00258	CcSEcCtD
Ephedrine—Insomnia—Irinotecan—lung cancer	0.00059	0.00255	CcSEcCtD
Ephedrine—Vomiting—Topotecan—lung cancer	0.000588	0.00254	CcSEcCtD
Ephedrine—Vertigo—Paclitaxel—lung cancer	0.000586	0.00253	CcSEcCtD
Ephedrine—Rash—Topotecan—lung cancer	0.000583	0.00252	CcSEcCtD
Ephedrine—Dermatitis—Topotecan—lung cancer	0.000583	0.00252	CcSEcCtD
Ephedrine—Vomiting—Erlotinib—lung cancer	0.000582	0.00252	CcSEcCtD
Ephedrine—Dyspnoea—Irinotecan—lung cancer	0.000582	0.00252	CcSEcCtD
Ephedrine—Headache—Topotecan—lung cancer	0.00058	0.00251	CcSEcCtD
Ephedrine—Tachycardia—Cisplatin—lung cancer	0.000579	0.0025	CcSEcCtD
Ephedrine—Rash—Erlotinib—lung cancer	0.000577	0.0025	CcSEcCtD
Ephedrine—Dermatitis—Erlotinib—lung cancer	0.000577	0.00249	CcSEcCtD
Ephedrine—Palpitations—Paclitaxel—lung cancer	0.000577	0.00249	CcSEcCtD
Ephedrine—Insomnia—Gemcitabine—lung cancer	0.000575	0.00249	CcSEcCtD
Ephedrine—Dyspepsia—Irinotecan—lung cancer	0.000575	0.00249	CcSEcCtD
Ephedrine—Hypertension—Etoposide—lung cancer	0.000574	0.00248	CcSEcCtD
Ephedrine—Headache—Erlotinib—lung cancer	0.000574	0.00248	CcSEcCtD
Ephedrine—Hyperhidrosis—Cisplatin—lung cancer	0.000573	0.00248	CcSEcCtD
Ephedrine—Asthenia—Vinorelbine—lung cancer	0.000568	0.00246	CcSEcCtD
Ephedrine—Decreased appetite—Irinotecan—lung cancer	0.000568	0.00245	CcSEcCtD
Ephedrine—Arrhythmia—Docetaxel—lung cancer	0.000567	0.00245	CcSEcCtD
Ephedrine—Dyspnoea—Gemcitabine—lung cancer	0.000567	0.00245	CcSEcCtD
Ephedrine—Chest pain—Etoposide—lung cancer	0.000566	0.00245	CcSEcCtD
Ephedrine—Nausea—Vinblastine—lung cancer	0.000566	0.00245	CcSEcCtD
Ephedrine—Anorexia—Cisplatin—lung cancer	0.000565	0.00244	CcSEcCtD
Ephedrine—Hypertension—Paclitaxel—lung cancer	0.000563	0.00244	CcSEcCtD
Ephedrine—Pain—Irinotecan—lung cancer	0.000558	0.00241	CcSEcCtD
Ephedrine—Chest pain—Paclitaxel—lung cancer	0.000555	0.0024	CcSEcCtD
Ephedrine—Anxiety—Paclitaxel—lung cancer	0.000553	0.00239	CcSEcCtD
Ephedrine—Decreased appetite—Gemcitabine—lung cancer	0.000553	0.00239	CcSEcCtD
Ephedrine—Nausea—Topotecan—lung cancer	0.00055	0.00238	CcSEcCtD
Ephedrine—Confusional state—Etoposide—lung cancer	0.000548	0.00237	CcSEcCtD
Ephedrine—BCHE—trachea—lung cancer	0.000544	0.0384	CbGeAlD
Ephedrine—ACHE—lymph node—lung cancer	0.000544	0.0384	CbGeAlD
Ephedrine—Pain—Gemcitabine—lung cancer	0.000544	0.00235	CcSEcCtD
Ephedrine—Nausea—Erlotinib—lung cancer	0.000544	0.00235	CcSEcCtD
Ephedrine—Feeling abnormal—Irinotecan—lung cancer	0.000538	0.00233	CcSEcCtD
Ephedrine—Confusional state—Paclitaxel—lung cancer	0.000537	0.00232	CcSEcCtD
Ephedrine—Dysuria—Methotrexate—lung cancer	0.000535	0.00231	CcSEcCtD
Ephedrine—Muscle spasms—Docetaxel—lung cancer	0.000532	0.0023	CcSEcCtD
Ephedrine—SLC18A2—lymph node—lung cancer	0.00053	0.0374	CbGeAlD
Ephedrine—Tachycardia—Etoposide—lung cancer	0.00053	0.00229	CcSEcCtD
Ephedrine—Dyspnoea—Cisplatin—lung cancer	0.000528	0.00229	CcSEcCtD
Ephedrine—Hyperhidrosis—Etoposide—lung cancer	0.000525	0.00227	CcSEcCtD
Ephedrine—Feeling abnormal—Gemcitabine—lung cancer	0.000524	0.00227	CcSEcCtD
Ephedrine—Dizziness—Vinorelbine—lung cancer	0.000523	0.00226	CcSEcCtD
Ephedrine—Tachycardia—Paclitaxel—lung cancer	0.00052	0.00225	CcSEcCtD
Ephedrine—Anorexia—Etoposide—lung cancer	0.000518	0.00224	CcSEcCtD
Ephedrine—Body temperature increased—Irinotecan—lung cancer	0.000516	0.00223	CcSEcCtD
Ephedrine—Decreased appetite—Cisplatin—lung cancer	0.000515	0.00223	CcSEcCtD
Ephedrine—Hyperhidrosis—Paclitaxel—lung cancer	0.000515	0.00223	CcSEcCtD
Ephedrine—BCHE—cardiac atrium—lung cancer	0.000511	0.0361	CbGeAlD
Ephedrine—Anorexia—Paclitaxel—lung cancer	0.000508	0.00219	CcSEcCtD
Ephedrine—Pain—Cisplatin—lung cancer	0.000507	0.00219	CcSEcCtD
Ephedrine—Vomiting—Vinorelbine—lung cancer	0.000503	0.00218	CcSEcCtD
Ephedrine—Body temperature increased—Gemcitabine—lung cancer	0.000503	0.00217	CcSEcCtD
Ephedrine—Rash—Vinorelbine—lung cancer	0.000499	0.00216	CcSEcCtD
Ephedrine—Dermatitis—Vinorelbine—lung cancer	0.000499	0.00216	CcSEcCtD
Ephedrine—Headache—Vinorelbine—lung cancer	0.000496	0.00214	CcSEcCtD
Ephedrine—Sweating—Methotrexate—lung cancer	0.000489	0.00211	CcSEcCtD
Ephedrine—Palpitations—Docetaxel—lung cancer	0.000489	0.00211	CcSEcCtD
Ephedrine—Feeling abnormal—Cisplatin—lung cancer	0.000488	0.00211	CcSEcCtD
Ephedrine—Dyspnoea—Etoposide—lung cancer	0.000484	0.00209	CcSEcCtD
Ephedrine—Angina pectoris—Doxorubicin—lung cancer	0.000482	0.00209	CcSEcCtD
Ephedrine—Insomnia—Paclitaxel—lung cancer	0.000482	0.00208	CcSEcCtD
Ephedrine—Hypertension—Docetaxel—lung cancer	0.000477	0.00206	CcSEcCtD
Ephedrine—Dyspnoea—Paclitaxel—lung cancer	0.000475	0.00205	CcSEcCtD
Ephedrine—SLC6A2—lung—lung cancer	0.000473	0.0334	CbGeAlD
Ephedrine—Decreased appetite—Etoposide—lung cancer	0.000472	0.00204	CcSEcCtD
Ephedrine—Chest pain—Docetaxel—lung cancer	0.000471	0.00204	CcSEcCtD
Ephedrine—Nausea—Vinorelbine—lung cancer	0.00047	0.00203	CcSEcCtD
Ephedrine—Dyspepsia—Paclitaxel—lung cancer	0.000469	0.00203	CcSEcCtD
Ephedrine—Body temperature increased—Cisplatin—lung cancer	0.000469	0.00203	CcSEcCtD
Ephedrine—Asthenia—Irinotecan—lung cancer	0.000468	0.00203	CcSEcCtD
Ephedrine—Pain—Etoposide—lung cancer	0.000464	0.00201	CcSEcCtD
Ephedrine—Dysuria—Doxorubicin—lung cancer	0.000463	0.002	CcSEcCtD
Ephedrine—Decreased appetite—Paclitaxel—lung cancer	0.000463	0.002	CcSEcCtD
Ephedrine—Asthenia—Gemcitabine—lung cancer	0.000456	0.00197	CcSEcCtD
Ephedrine—Pain—Paclitaxel—lung cancer	0.000455	0.00197	CcSEcCtD
Ephedrine—Confusional state—Docetaxel—lung cancer	0.000455	0.00197	CcSEcCtD
Ephedrine—Feeling abnormal—Etoposide—lung cancer	0.000447	0.00194	CcSEcCtD
Ephedrine—Tachycardia—Docetaxel—lung cancer	0.00044	0.0019	CcSEcCtD
Ephedrine—Feeling abnormal—Paclitaxel—lung cancer	0.000439	0.0019	CcSEcCtD
Ephedrine—Dizziness—Irinotecan—lung cancer	0.000432	0.00187	CcSEcCtD
Ephedrine—BCHE—bone marrow—lung cancer	0.000432	0.0305	CbGeAlD
Ephedrine—Anorexia—Docetaxel—lung cancer	0.00043	0.00186	CcSEcCtD
Ephedrine—Body temperature increased—Etoposide—lung cancer	0.000429	0.00186	CcSEcCtD
Ephedrine—Asthenia—Cisplatin—lung cancer	0.000425	0.00184	CcSEcCtD
Ephedrine—Sweating—Doxorubicin—lung cancer	0.000423	0.00183	CcSEcCtD
Ephedrine—Body temperature increased—Paclitaxel—lung cancer	0.000421	0.00182	CcSEcCtD
Ephedrine—Vomiting—Irinotecan—lung cancer	0.000415	0.00179	CcSEcCtD
Ephedrine—Rash—Irinotecan—lung cancer	0.000412	0.00178	CcSEcCtD
Ephedrine—Dermatitis—Irinotecan—lung cancer	0.000411	0.00178	CcSEcCtD
Ephedrine—Headache—Irinotecan—lung cancer	0.000409	0.00177	CcSEcCtD
Ephedrine—Insomnia—Docetaxel—lung cancer	0.000408	0.00177	CcSEcCtD
Ephedrine—Vomiting—Gemcitabine—lung cancer	0.000404	0.00175	CcSEcCtD
Ephedrine—Bradycardia—Doxorubicin—lung cancer	0.000404	0.00175	CcSEcCtD
Ephedrine—Dyspnoea—Docetaxel—lung cancer	0.000402	0.00174	CcSEcCtD
Ephedrine—Rash—Gemcitabine—lung cancer	0.000401	0.00173	CcSEcCtD
Ephedrine—Dermatitis—Gemcitabine—lung cancer	0.000401	0.00173	CcSEcCtD
Ephedrine—Headache—Gemcitabine—lung cancer	0.000398	0.00172	CcSEcCtD
Ephedrine—Dyspepsia—Docetaxel—lung cancer	0.000397	0.00172	CcSEcCtD
Ephedrine—Decreased appetite—Docetaxel—lung cancer	0.000392	0.0017	CcSEcCtD
Ephedrine—BCHE—lung—lung cancer	0.000391	0.0276	CbGeAlD
Ephedrine—Asthenia—Etoposide—lung cancer	0.00039	0.00168	CcSEcCtD
Ephedrine—Nausea—Irinotecan—lung cancer	0.000388	0.00168	CcSEcCtD
Ephedrine—Pain—Docetaxel—lung cancer	0.000386	0.00167	CcSEcCtD
Ephedrine—Asthenia—Paclitaxel—lung cancer	0.000382	0.00165	CcSEcCtD
Ephedrine—Nausea—Gemcitabine—lung cancer	0.000378	0.00163	CcSEcCtD
Ephedrine—Vomiting—Cisplatin—lung cancer	0.000377	0.00163	CcSEcCtD
Ephedrine—Rash—Cisplatin—lung cancer	0.000374	0.00162	CcSEcCtD
Ephedrine—Dermatitis—Cisplatin—lung cancer	0.000373	0.00161	CcSEcCtD
Ephedrine—Feeling abnormal—Docetaxel—lung cancer	0.000372	0.00161	CcSEcCtD
Ephedrine—Dizziness—Etoposide—lung cancer	0.000359	0.00155	CcSEcCtD
Ephedrine—Vertigo—Methotrexate—lung cancer	0.000358	0.00155	CcSEcCtD
Ephedrine—Body temperature increased—Docetaxel—lung cancer	0.000357	0.00154	CcSEcCtD
Ephedrine—Arrhythmia—Doxorubicin—lung cancer	0.000354	0.00153	CcSEcCtD
Ephedrine—Dizziness—Paclitaxel—lung cancer	0.000352	0.00152	CcSEcCtD
Ephedrine—Nausea—Cisplatin—lung cancer	0.000352	0.00152	CcSEcCtD
Ephedrine—Selegiline—ABCB1—lung cancer	0.000348	0.0518	CrCbGaD
Ephedrine—Vomiting—Etoposide—lung cancer	0.000345	0.00149	CcSEcCtD
Ephedrine—Rash—Etoposide—lung cancer	0.000342	0.00148	CcSEcCtD
Ephedrine—Dermatitis—Etoposide—lung cancer	0.000342	0.00148	CcSEcCtD
Ephedrine—Headache—Etoposide—lung cancer	0.00034	0.00147	CcSEcCtD
Ephedrine—Chest pain—Methotrexate—lung cancer	0.000339	0.00147	CcSEcCtD
Ephedrine—Tension—Doxorubicin—lung cancer	0.000339	0.00146	CcSEcCtD
Ephedrine—Vomiting—Paclitaxel—lung cancer	0.000339	0.00146	CcSEcCtD
Ephedrine—Rash—Paclitaxel—lung cancer	0.000336	0.00145	CcSEcCtD
Ephedrine—Dermatitis—Paclitaxel—lung cancer	0.000335	0.00145	CcSEcCtD
Ephedrine—Nervousness—Doxorubicin—lung cancer	0.000335	0.00145	CcSEcCtD
Ephedrine—Headache—Paclitaxel—lung cancer	0.000334	0.00144	CcSEcCtD
Ephedrine—Muscle spasms—Doxorubicin—lung cancer	0.000332	0.00143	CcSEcCtD
Ephedrine—Confusional state—Methotrexate—lung cancer	0.000328	0.00142	CcSEcCtD
Ephedrine—Asthenia—Docetaxel—lung cancer	0.000324	0.0014	CcSEcCtD
Ephedrine—SLC6A2—lymph node—lung cancer	0.000324	0.0228	CbGeAlD
Ephedrine—Nausea—Etoposide—lung cancer	0.000323	0.00139	CcSEcCtD
Ephedrine—Agitation—Doxorubicin—lung cancer	0.000317	0.00137	CcSEcCtD
Ephedrine—Nausea—Paclitaxel—lung cancer	0.000316	0.00137	CcSEcCtD
Ephedrine—Hyperhidrosis—Methotrexate—lung cancer	0.000314	0.00136	CcSEcCtD
Ephedrine—Vertigo—Doxorubicin—lung cancer	0.00031	0.00134	CcSEcCtD
Ephedrine—Anorexia—Methotrexate—lung cancer	0.00031	0.00134	CcSEcCtD
Ephedrine—Palpitations—Doxorubicin—lung cancer	0.000305	0.00132	CcSEcCtD
Ephedrine—Dizziness—Docetaxel—lung cancer	0.000298	0.00129	CcSEcCtD
Ephedrine—Hypertension—Doxorubicin—lung cancer	0.000298	0.00129	CcSEcCtD
Ephedrine—Insomnia—Methotrexate—lung cancer	0.000294	0.00127	CcSEcCtD
Ephedrine—Chest pain—Doxorubicin—lung cancer	0.000294	0.00127	CcSEcCtD
Ephedrine—Anxiety—Doxorubicin—lung cancer	0.000293	0.00127	CcSEcCtD
Ephedrine—Dyspnoea—Methotrexate—lung cancer	0.00029	0.00125	CcSEcCtD
Ephedrine—Vomiting—Docetaxel—lung cancer	0.000287	0.00124	CcSEcCtD
Ephedrine—Dyspepsia—Methotrexate—lung cancer	0.000286	0.00124	CcSEcCtD
Ephedrine—Rash—Docetaxel—lung cancer	0.000285	0.00123	CcSEcCtD
Ephedrine—Dermatitis—Docetaxel—lung cancer	0.000284	0.00123	CcSEcCtD
Ephedrine—Confusional state—Doxorubicin—lung cancer	0.000284	0.00123	CcSEcCtD
Ephedrine—Decreased appetite—Methotrexate—lung cancer	0.000283	0.00122	CcSEcCtD
Ephedrine—Headache—Docetaxel—lung cancer	0.000283	0.00122	CcSEcCtD
Ephedrine—Pain—Methotrexate—lung cancer	0.000278	0.0012	CcSEcCtD
Ephedrine—Tachycardia—Doxorubicin—lung cancer	0.000275	0.00119	CcSEcCtD
Ephedrine—Hyperhidrosis—Doxorubicin—lung cancer	0.000272	0.00118	CcSEcCtD
Ephedrine—Anorexia—Doxorubicin—lung cancer	0.000268	0.00116	CcSEcCtD
Ephedrine—Nausea—Docetaxel—lung cancer	0.000268	0.00116	CcSEcCtD
Ephedrine—Feeling abnormal—Methotrexate—lung cancer	0.000268	0.00116	CcSEcCtD
Ephedrine—BCHE—lymph node—lung cancer	0.000267	0.0189	CbGeAlD
Ephedrine—Body temperature increased—Methotrexate—lung cancer	0.000257	0.00111	CcSEcCtD
Ephedrine—Insomnia—Doxorubicin—lung cancer	0.000255	0.0011	CcSEcCtD
Ephedrine—Dyspnoea—Doxorubicin—lung cancer	0.000251	0.00109	CcSEcCtD
Ephedrine—Dyspepsia—Doxorubicin—lung cancer	0.000248	0.00107	CcSEcCtD
Ephedrine—Decreased appetite—Doxorubicin—lung cancer	0.000245	0.00106	CcSEcCtD
Ephedrine—Pain—Doxorubicin—lung cancer	0.000241	0.00104	CcSEcCtD
Ephedrine—Asthenia—Methotrexate—lung cancer	0.000233	0.00101	CcSEcCtD
Ephedrine—Feeling abnormal—Doxorubicin—lung cancer	0.000232	0.001	CcSEcCtD
Ephedrine—Body temperature increased—Doxorubicin—lung cancer	0.000223	0.000963	CcSEcCtD
Ephedrine—Dizziness—Methotrexate—lung cancer	0.000215	0.00093	CcSEcCtD
Ephedrine—Vomiting—Methotrexate—lung cancer	0.000207	0.000894	CcSEcCtD
Ephedrine—Rash—Methotrexate—lung cancer	0.000205	0.000887	CcSEcCtD
Ephedrine—Dermatitis—Methotrexate—lung cancer	0.000205	0.000886	CcSEcCtD
Ephedrine—Headache—Methotrexate—lung cancer	0.000204	0.000881	CcSEcCtD
Ephedrine—Asthenia—Doxorubicin—lung cancer	0.000202	0.000874	CcSEcCtD
Ephedrine—Nausea—Methotrexate—lung cancer	0.000193	0.000835	CcSEcCtD
Ephedrine—Dizziness—Doxorubicin—lung cancer	0.000186	0.000805	CcSEcCtD
Ephedrine—Vomiting—Doxorubicin—lung cancer	0.000179	0.000774	CcSEcCtD
Ephedrine—Rash—Doxorubicin—lung cancer	0.000178	0.000768	CcSEcCtD
Ephedrine—Dermatitis—Doxorubicin—lung cancer	0.000177	0.000767	CcSEcCtD
Ephedrine—Headache—Doxorubicin—lung cancer	0.000176	0.000763	CcSEcCtD
Ephedrine—Nausea—Doxorubicin—lung cancer	0.000167	0.000723	CcSEcCtD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.27e-05	0.000397	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SKI—lung cancer	5.26e-05	0.000397	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—NQO1—lung cancer	5.26e-05	0.000396	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.2e-05	0.000392	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (q) signalling events—PIK3CA—lung cancer	5.18e-05	0.00039	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.15e-05	0.000388	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—MMP2—lung cancer	5.14e-05	0.000387	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—HRAS—lung cancer	5.13e-05	0.000387	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.1e-05	0.000384	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GNG11—lung cancer	5.06e-05	0.000382	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—lung cancer	5.04e-05	0.00038	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CXCL8—lung cancer	4.98e-05	0.000375	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AVP—lung cancer	4.97e-05	0.000374	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—RAF1—lung cancer	4.95e-05	0.000373	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—POMC—lung cancer	4.93e-05	0.000371	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VEGFC—lung cancer	4.82e-05	0.000363	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP2E1—lung cancer	4.74e-05	0.000357	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—STK11—lung cancer	4.74e-05	0.000357	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—NQO1—lung cancer	4.69e-05	0.000353	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	4.63e-05	0.000349	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.59e-05	0.000346	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—MMP2—lung cancer	4.59e-05	0.000346	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—HRAS—lung cancer	4.58e-05	0.000345	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PXN—lung cancer	4.57e-05	0.000344	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ADCY1—lung cancer	4.55e-05	0.000343	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.55e-05	0.000343	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AVP—lung cancer	4.52e-05	0.000341	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKR1C1—lung cancer	4.47e-05	0.000337	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—OXTR—lung cancer	4.47e-05	0.000337	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GRP—lung cancer	4.47e-05	0.000337	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.45e-05	0.000335	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PPP2R1B—lung cancer	4.44e-05	0.000334	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SMARCA4—lung cancer	4.44e-05	0.000334	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTP1—lung cancer	4.38e-05	0.00033	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	4.28e-05	0.000323	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HSPB1—lung cancer	4.28e-05	0.000323	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—CXCL8—lung cancer	4.27e-05	0.000322	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CAT—lung cancer	4.27e-05	0.000321	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.24e-05	0.00032	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTHLH—lung cancer	4.23e-05	0.000319	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—STK11—lung cancer	4.23e-05	0.000318	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GNG11—lung cancer	4.19e-05	0.000316	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ABCB1—lung cancer	4.15e-05	0.000313	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CXCL8—lung cancer	4.12e-05	0.00031	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AVP—lung cancer	4.11e-05	0.00031	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	4.1e-05	0.000309	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—TYMS—lung cancer	4.08e-05	0.000307	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTM1—lung cancer	4.03e-05	0.000304	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VEGFC—lung cancer	3.99e-05	0.000301	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ANXA1—lung cancer	3.98e-05	0.0003	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.97e-05	0.000299	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTP1—lung cancer	3.91e-05	0.000295	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FLT1—lung cancer	3.85e-05	0.00029	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CG—lung cancer	3.82e-05	0.000288	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CYP1A1—lung cancer	3.82e-05	0.000288	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CXCL8—lung cancer	3.81e-05	0.000287	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CAT—lung cancer	3.81e-05	0.000287	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ERCC2—lung cancer	3.79e-05	0.000285	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.78e-05	0.000285	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NOTCH3—lung cancer	3.77e-05	0.000284	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APP—lung cancer	3.77e-05	0.000284	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ADCY1—lung cancer	3.77e-05	0.000284	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGF9—lung cancer	3.74e-05	0.000282	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ABCB1—lung cancer	3.7e-05	0.000279	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PPP2R1B—lung cancer	3.67e-05	0.000277	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SMARCA4—lung cancer	3.67e-05	0.000277	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—TYMS—lung cancer	3.64e-05	0.000274	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—POMC—lung cancer	3.64e-05	0.000274	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTM1—lung cancer	3.59e-05	0.000271	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—JUNB—lung cancer	3.57e-05	0.000269	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HSPB1—lung cancer	3.54e-05	0.000267	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTHLH—lung cancer	3.5e-05	0.000264	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CG—lung cancer	3.47e-05	0.000261	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP1A1—lung cancer	3.41e-05	0.000257	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ERCC2—lung cancer	3.38e-05	0.000255	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CD—lung cancer	3.36e-05	0.000253	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—POMC—lung cancer	3.3e-05	0.000249	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ANXA1—lung cancer	3.29e-05	0.000248	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—APOA1—lung cancer	3.28e-05	0.000247	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—STK11—lung cancer	3.24e-05	0.000244	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL6R—lung cancer	3.22e-05	0.000243	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FLT1—lung cancer	3.19e-05	0.00024	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CG—lung cancer	3.16e-05	0.000238	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.14e-05	0.000236	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FOXO3—lung cancer	3.13e-05	0.000236	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APP—lung cancer	3.12e-05	0.000235	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOTCH3—lung cancer	3.12e-05	0.000235	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGF9—lung cancer	3.1e-05	0.000233	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—MAP2K1—lung cancer	3.07e-05	0.000231	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CD—lung cancer	3.05e-05	0.00023	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—POMC—lung cancer	3.01e-05	0.000227	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CG—lung cancer	2.99e-05	0.000225	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—JUNB—lung cancer	2.96e-05	0.000223	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AVP—lung cancer	2.93e-05	0.000221	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CB—lung cancer	2.93e-05	0.00022	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APOA1—lung cancer	2.92e-05	0.00022	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CG—lung cancer	2.87e-05	0.000216	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—POMC—lung cancer	2.85e-05	0.000215	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IGF1R—lung cancer	2.82e-05	0.000213	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CXCL8—lung cancer	2.81e-05	0.000212	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.8e-05	0.000211	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CD—lung cancer	2.78e-05	0.000209	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HES1—lung cancer	2.77e-05	0.000209	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CREBBP—lung cancer	2.77e-05	0.000209	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—POMC—lung cancer	2.73e-05	0.000206	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—RAF1—lung cancer	2.72e-05	0.000205	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—IL2—lung cancer	2.69e-05	0.000202	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—STK11—lung cancer	2.68e-05	0.000202	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CG—lung cancer	2.67e-05	0.000201	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL6R—lung cancer	2.66e-05	0.000201	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CB—lung cancer	2.66e-05	0.0002	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CD—lung cancer	2.63e-05	0.000198	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ALB—lung cancer	2.6e-05	0.000196	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FOXO3—lung cancer	2.59e-05	0.000195	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CXCL8—lung cancer	2.55e-05	0.000192	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—POMC—lung cancer	2.54e-05	0.000191	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—MAP2K1—lung cancer	2.54e-05	0.000191	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ERBB3—lung cancer	2.54e-05	0.000191	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CD—lung cancer	2.52e-05	0.00019	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CREBBP—lung cancer	2.47e-05	0.000186	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL2—lung cancer	2.44e-05	0.000184	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TERT—lung cancer	2.43e-05	0.000183	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AVP—lung cancer	2.43e-05	0.000183	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CB—lung cancer	2.42e-05	0.000182	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGFR1—lung cancer	2.36e-05	0.000178	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CD—lung cancer	2.35e-05	0.000177	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IGF1R—lung cancer	2.34e-05	0.000176	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CXCL8—lung cancer	2.33e-05	0.000175	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HIF1A—lung cancer	2.33e-05	0.000175	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ALB—lung cancer	2.32e-05	0.000174	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HES1—lung cancer	2.3e-05	0.000173	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CB—lung cancer	2.29e-05	0.000173	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTGS2—lung cancer	2.27e-05	0.000171	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—RAF1—lung cancer	2.25e-05	0.00017	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APOA1—lung cancer	2.24e-05	0.000169	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KDR—lung cancer	2.22e-05	0.000168	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—IL2—lung cancer	2.22e-05	0.000167	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CB—lung cancer	2.2e-05	0.000166	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CXCL8—lung cancer	2.11e-05	0.000159	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ERBB3—lung cancer	2.1e-05	0.000158	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KIT—lung cancer	2.05e-05	0.000154	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APC—lung cancer	2.05e-05	0.000154	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CG—lung cancer	2.05e-05	0.000154	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—NRAS—lung cancer	2.05e-05	0.000154	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CB—lung cancer	2.04e-05	0.000154	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTGS2—lung cancer	2.03e-05	0.000153	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EGF—lung cancer	2.02e-05	0.000153	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL2—lung cancer	2.02e-05	0.000152	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TERT—lung cancer	2.01e-05	0.000152	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTEN—lung cancer	1.98e-05	0.000149	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—MAPK3—lung cancer	1.96e-05	0.000148	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGFR1—lung cancer	1.95e-05	0.000147	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—POMC—lung cancer	1.95e-05	0.000147	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—BRAF—lung cancer	1.93e-05	0.000145	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HIF1A—lung cancer	1.92e-05	0.000145	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL6R—lung cancer	1.9e-05	0.000143	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CREBBP—lung cancer	1.9e-05	0.000143	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—EP300—lung cancer	1.89e-05	0.000142	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—EGFR—lung cancer	1.87e-05	0.000141	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOA1—lung cancer	1.86e-05	0.00014	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KDR—lung cancer	1.84e-05	0.000139	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAP2K1—lung cancer	1.81e-05	0.000137	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CD—lung cancer	1.8e-05	0.000136	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CA—lung cancer	1.78e-05	0.000134	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTEN—lung cancer	1.77e-05	0.000133	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—KRAS—lung cancer	1.76e-05	0.000133	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CG—lung cancer	1.69e-05	0.000128	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APC—lung cancer	1.69e-05	0.000128	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KIT—lung cancer	1.69e-05	0.000128	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—NRAS—lung cancer	1.69e-05	0.000128	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—EP300—lung cancer	1.69e-05	0.000127	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EGF—lung cancer	1.67e-05	0.000126	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—MAPK3—lung cancer	1.62e-05	0.000122	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CA—lung cancer	1.62e-05	0.000122	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MDM2—lung cancer	1.61e-05	0.000122	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—POMC—lung cancer	1.61e-05	0.000122	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RAF1—lung cancer	1.61e-05	0.000121	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—BRAF—lung cancer	1.59e-05	0.00012	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ERBB2—lung cancer	1.59e-05	0.00012	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL6R—lung cancer	1.57e-05	0.000119	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CREBBP—lung cancer	1.57e-05	0.000118	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CB—lung cancer	1.57e-05	0.000118	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MTOR—lung cancer	1.57e-05	0.000118	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—EGFR—lung cancer	1.54e-05	0.000116	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CXCL8—lung cancer	1.51e-05	0.000114	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAP2K1—lung cancer	1.5e-05	0.000113	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—HRAS—lung cancer	1.5e-05	0.000113	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CD—lung cancer	1.49e-05	0.000112	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CA—lung cancer	1.48e-05	0.000111	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—KRAS—lung cancer	1.46e-05	0.00011	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AKT1—lung cancer	1.46e-05	0.00011	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CASP3—lung cancer	1.44e-05	0.000109	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL2—lung cancer	1.44e-05	0.000109	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL6—lung cancer	1.43e-05	0.000108	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCND1—lung cancer	1.41e-05	0.000106	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—JUN—lung cancer	1.4e-05	0.000106	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CA—lung cancer	1.4e-05	0.000105	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MMP9—lung cancer	1.36e-05	0.000103	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CDKN1A—lung cancer	1.36e-05	0.000102	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTEN—lung cancer	1.36e-05	0.000102	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CA—lung cancer	1.34e-05	0.000101	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MDM2—lung cancer	1.33e-05	0.000101	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RAF1—lung cancer	1.33e-05	0.0001	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AKT1—lung cancer	1.32e-05	9.97e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ERBB2—lung cancer	1.32e-05	9.91e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MTOR—lung cancer	1.3e-05	9.78e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CB—lung cancer	1.3e-05	9.78e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EP300—lung cancer	1.29e-05	9.75e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SRC—lung cancer	1.26e-05	9.48e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCL8—lung cancer	1.25e-05	9.4e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CA—lung cancer	1.25e-05	9.39e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—HRAS—lung cancer	1.24e-05	9.34e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VEGFA—lung cancer	1.23e-05	9.23e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—STAT3—lung cancer	1.21e-05	9.14e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NRAS—lung cancer	1.21e-05	9.12e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	1.21e-05	9.08e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CASP3—lung cancer	1.19e-05	9e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL2—lung cancer	1.19e-05	8.98e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL6—lung cancer	1.19e-05	8.94e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCND1—lung cancer	1.16e-05	8.76e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—JUN—lung cancer	1.16e-05	8.74e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAPK3—lung cancer	1.16e-05	8.73e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—AKT1—lung cancer	1.14e-05	8.6e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MMP9—lung cancer	1.13e-05	8.5e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MYC—lung cancer	1.13e-05	8.49e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	1.12e-05	8.47e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTEN—lung cancer	1.12e-05	8.45e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EGFR—lung cancer	1.1e-05	8.31e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AKT1—lung cancer	1.09e-05	8.25e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EP300—lung cancer	1.07e-05	8.06e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KRAS—lung cancer	1.04e-05	7.85e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SRC—lung cancer	1.04e-05	7.84e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—AKT1—lung cancer	1.02e-05	7.67e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	1.01e-05	7.64e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—STAT3—lung cancer	1e-05	7.56e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NRAS—lung cancer	1e-05	7.54e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	9.59e-06	7.22e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CA—lung cancer	9.57e-06	7.21e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MYC—lung cancer	9.32e-06	7.03e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TP53—lung cancer	9.26e-06	6.97e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EGFR—lung cancer	9.12e-06	6.87e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HRAS—lung cancer	8.85e-06	6.67e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KRAS—lung cancer	8.62e-06	6.49e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL6—lung cancer	8.47e-06	6.38e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	7.92e-06	5.96e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AKT1—lung cancer	7.82e-06	5.89e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TP53—lung cancer	7.66e-06	5.77e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HRAS—lung cancer	7.32e-06	5.52e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL6—lung cancer	7.01e-06	5.28e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKT1—lung cancer	6.47e-06	4.87e-05	CbGpPWpGaD
